The Cooper Cos., Inc. (COO)
75.80
-0.42
(-0.55%)
USD |
NASDAQ |
Aug 24, 16:00
75.92
+0.12
(+0.16%)
After-Hours: 20:00
Cooper Cos. Net Income (Quarterly) : -77.90M for April 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -77.90M |
| January 31, 2026 | 130.80M |
| October 31, 2025 | 84.60M |
| July 31, 2025 | 98.30M |
| April 30, 2025 | 87.70M |
| January 31, 2025 | 104.30M |
| October 31, 2024 | 117.50M |
| July 31, 2024 | 104.70M |
| April 30, 2024 | 88.90M |
| January 31, 2024 | 81.20M |
| October 31, 2023 | 84.50M |
| July 31, 2023 | 85.30M |
| April 30, 2023 | 39.80M |
| January 31, 2023 | 84.60M |
| October 31, 2022 | 65.60M |
| July 31, 2022 | 98.40M |
| April 30, 2022 | 126.60M |
| January 31, 2022 | 95.30M |
| October 31, 2021 | 110.30M |
| July 31, 2021 | 615.80M |
| April 30, 2021 | 117.50M |
| January 31, 2021 | 2.101B |
| October 31, 2020 | 81.20M |
| July 31, 2020 | 55.20M |
| April 30, 2020 | 11.50M |
| Date | Value |
|---|---|
| January 31, 2020 | 90.50M |
| October 31, 2019 | 121.00M |
| July 31, 2019 | 120.10M |
| April 30, 2019 | 122.40M |
| January 31, 2019 | 103.20M |
| October 31, 2018 | 100.60M |
| July 31, 2018 | 100.80M |
| April 30, 2018 | 60.90M |
| January 31, 2018 | -122.50M |
| October 31, 2017 | 88.60M |
| July 31, 2017 | 103.60M |
| April 30, 2017 | 104.90M |
| January 31, 2017 | 75.80M |
| October 31, 2016 | 60.49M |
| July 31, 2016 | 88.20M |
| April 30, 2016 | 74.46M |
| January 31, 2016 | 51.74M |
| October 31, 2015 | 37.02M |
| July 31, 2015 | 45.24M |
| April 30, 2015 | 61.14M |
| January 31, 2015 | 61.75M |
| October 31, 2014 | 31.26M |
| July 31, 2014 | 88.67M |
| April 30, 2014 | 79.64M |
| January 31, 2014 | 72.26M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 151.57M |
| West Pharmaceutical Services, Inc. | 154.00M |
| Abbott Laboratories | 928.00M |
| Stryker Corp. | 1.276B |
| Solventum Corp. | 92.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.082B |
| Total Expenses (Quarterly) | 1.159B |
| EPS Diluted (Quarterly) | -0.3995 |
| Enterprise Value | 17.09B |
| Gross Profit Margin (Quarterly) | 63.59% |
| Profit Margin (Quarterly) | -7.20% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 2.848 |